Page last updated: 2024-08-21

dehydroepiandrosterone sulfate and Cystadenocarcinoma, Serous

dehydroepiandrosterone sulfate has been researched along with Cystadenocarcinoma, Serous in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ino, K; Kajiyama, H; Kikkawa, F; Mizutani, S; Morita, T; Nagasaka, T; Shibata, K; Suzuki, T1
Bennett, P; Blaakaer, J; Bock, J; Daugaard, S; Høgdall, CK; Hørding, U; Toftager-Larsen, K1

Other Studies

2 other study(ies) available for dehydroepiandrosterone sulfate and Cystadenocarcinoma, Serous

ArticleYear
Cushing's syndrome due to ovarian serous adenocarcinoma secreting multiple endocrine substances: a case report and immunohistochemical analysis.
    Gynecologic oncology, 2003, Volume: 90, Issue:3

    Topics: Adrenocorticotropic Hormone; Aged; alpha-Fetoproteins; Cushing Syndrome; Cystadenocarcinoma, Serous; Dehydroepiandrosterone Sulfate; Estradiol; Female; Humans; Immunohistochemistry; Neurophysins; Ovarian Neoplasms; Parathyroid Hormone; Protein Precursors; Vasopressins

2003
Hormonal factors and prognosis in epithelial ovarian cancer: a multivariate analysis.
    European journal of obstetrics, gynecology, and reproductive biology, 1993, Volume: 51, Issue:1

    Topics: Adenocarcinoma; Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Aging; Androstenedione; Carcinoma, Endometrioid; Cystadenocarcinoma, Serous; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Female; Follicle Stimulating Hormone; Hormones; Humans; Luteinizing Hormone; Multivariate Analysis; Neoplasm Staging; Ovarian Neoplasms; Progesterone; Prognosis; Regression Analysis; Testosterone

1993